International Edition
World Markets FX Policy

Friday, 13 November 2026

Private Trade News

Global markets, trading & world business — for professional traders

Markets

MiNK Therapeutics Reports Third Quarter 2026 Results and First Pre-Commercial Product Revenue

Private Trade News trader edition (2026-11-13): MiNK Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, recognizing its first pre-commercial product revenue of… Primary source: original at Nasdaq (nasdaq.com).

· Nasdaq

MiNK Therapeutics Reports Third Quarter 2026 Results and First Pre-Commercial Product Revenue

MiNK Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, recognizing its first pre-commercial product revenue of $0.2 million from its lead candidate, agenT-797. This revenue was generated through its international named-patient acces

Read at source

Read also